Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices

Mol Cell Neurosci. 2004 Feb;25(2):301-11. doi: 10.1016/j.mcn.2003.10.022.

Abstract

We investigated the effects of IL-6 and a chimeric derivative of IL-6 and soluble IL-6 receptor (IL6RIL6 chimera) on excitotoxic injury in rat organotypic hippocampal slices. Brief application of N-methyl-d-aspartate (NMDA) induced astrocyte reactivity, neuron cell death, and oligodendrocyte degeneration, the latter caused by secondary activation of AMPA/kainate receptors. Both these cytokines rescued neurons and oligodendrocytes, albeit the chimeric compound was much more potent and efficient than IL-6. No change was produced on reactive astrocytosis. The cytokines preserved myelin basic protein (MBP) production in slices exposed to excitotoxic insult, and when applied singularly for a week, they also enhanced both MBP and proteolipid protein expression. These effects occurred through activating the signal transducer gp130 and were associated with stimulation of transcription factors STAT1 and STAT3. Our results suggest that IL-6 and IL6RIL6 may prove to be valuable in treating neurodegenerative and demyelinating diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Active Transport, Cell Nucleus / genetics
  • Animals
  • Antigens, CD / metabolism
  • Astrocytes / drug effects
  • Astrocytes / physiology
  • Brain Ischemia / drug therapy
  • Brain Ischemia / metabolism
  • Brain Ischemia / physiopathology
  • Cytokine Receptor gp130
  • DNA-Binding Proteins / drug effects
  • DNA-Binding Proteins / metabolism
  • Gliosis / physiopathology
  • Gliosis / prevention & control
  • Hippocampus / cytology
  • In Vitro Techniques
  • Interleukin-6 / genetics
  • Interleukin-6 / pharmacology*
  • Membrane Glycoproteins / metabolism
  • Myelin Basic Protein / genetics
  • Myelin Proteolipid Protein / genetics
  • N-Methylaspartate / antagonists & inhibitors
  • Nerve Degeneration / drug therapy
  • Nerve Degeneration / metabolism
  • Nerve Degeneration / prevention & control*
  • Neurons / drug effects*
  • Neurons / metabolism
  • Neuroprotective Agents / pharmacology*
  • Neurotoxins / antagonists & inhibitors
  • Oligodendroglia / drug effects
  • Oligodendroglia / metabolism
  • Phosphorylation / drug effects
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Rats
  • Receptors, Interleukin-6 / genetics
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / pharmacology*
  • STAT1 Transcription Factor
  • STAT3 Transcription Factor
  • Trans-Activators / drug effects
  • Trans-Activators / metabolism

Substances

  • Antigens, CD
  • DNA-Binding Proteins
  • Il6st protein, rat
  • Interleukin-6
  • Membrane Glycoproteins
  • Myelin Basic Protein
  • Myelin Proteolipid Protein
  • Neuroprotective Agents
  • Neurotoxins
  • RNA, Messenger
  • Receptors, Interleukin-6
  • Recombinant Fusion Proteins
  • STAT1 Transcription Factor
  • STAT3 Transcription Factor
  • Stat1 protein, rat
  • Stat3 protein, rat
  • Trans-Activators
  • Cytokine Receptor gp130
  • N-Methylaspartate